Clinical trial
In-vivo Effects of E-cigarette Aerosol on Innate Lung Host Defense
NCT03700892 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- In-vivo Effects of E-cigarette Aerosol on Innate Lung Host Defense
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 19, 2018
- Completion date
- March 3, 2020
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy, smoking